Literature DB >> 11289193

Syphilis outbreak assessment.

L Finelli1, W C Levine, J Valentine, M E St Louis.   

Abstract

BACKGROUND: Syphilis rates began to decline in 1991 and have decreased every year since. In 1998, 6,993 cases of primary and secondary syphilis were reported in the United States, for a national incidence of 2.6 cases per 100,000 population. Although syphilis rates are at an historic low, focal outbreaks still occur. On October 7, 1999, the Division of Sexually Transmitted Disease Prevention of the Centers for Disease Control and Prevention, in collaboration with federal and community partners, presented the National Plan for Elimination of Syphilis from the United States. One of the five key strategies of the plan is rapid outbreak response.
METHODS: Methods for outbreak assessment and response were reviewed in the literature, synthesized, and adapted for use in syphilis outbreaks.
RESULTS: Key elements of outbreak assessment and response are detection, surveillance data review, hypothesis generation, intervention development, and the evaluation of clinical, public health, and laboratory services.
CONCLUSIONS: Outbreak response necessitates community participation and a coordinated interdisciplinary effort to determine social and behavioral contributors to the outbreak and to develop targeted interventions.

Mesh:

Year:  2001        PMID: 11289193     DOI: 10.1097/00007435-200103000-00002

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  2 in total

1.  Syphilis outbreak among American Indians - Arizona, 2007-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-02-19       Impact factor: 17.586

Review 2.  Control of syphilis outbreaks in men who have sex with men: the role of screening in nonmedical settings.

Authors:  Carol Ciesielski; Richard H Kahn; Melanie Taylor; Kathleen Gallagher; Larry J Prescott; Susan Arrowsmith
Journal:  Sex Transm Dis       Date:  2005-10       Impact factor: 2.830

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.